NCT05162339View on ClinicalTrials.gov

Inflammatory Bowel Disease and Thromboembolic Events

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

November 1, 2016

Primary Completion Date

April 30, 2020

Study Completion Date

April 30, 2020

Conditions
Inflammatory Bowel DiseasesThromboembolismCoagulation Disorder
Interventions
OTHER

No intervention was made

No intervention was made

Trial Locations (1)

3504-509

Centro Hospitalar Tondela Viseu, Viseu

All Listed Sponsors
collaborator

Portuguese IBD Group

UNKNOWN

lead

Centro Hospitalar Tondela-Viseu

OTHER

NCT05162339 - Inflammatory Bowel Disease and Thromboembolic Events | Biotech Hunter | Biotech Hunter